Altintas U, Lawaetz M, de la Motte L, et al. - Compared with open repair of chronic mesenteric ischemia (CMI), endovascular treatment is correlated with low early morbidity and mortality but a higher risk of recurrence. Researchers here investigated short and mid term outcome after first line endovascular revascularization of CMI and acute on chronic mesenteric ischemia (AoCMI) via performing a prospective population and registry based cohort study supplemented by a retrospective review of medical records and imaging files. From the Danish National Registry for Vascular Surgery (Karbase), they identified a total of 245 patients who had an endovascular intervention for CMI ( n = 178; 72.6%) and AoCMI ( n = 67; 27.3%) between 2011 and 2015. Analyses revealed a 3 year mortality rate of 25% in correlation with undergoing first line endovascular treatment of CMI, and there was a low risk of recurrence of symptomatic ischemia. They observed significantly higher morbidity and mortality, more bowel resections, and longer length of hospital stay among patients suffering AoCMI relative to those with CMI.